Neuroendocrine Neoplasms of the Small Bowel and Pancreas.
Ontology highlight
ABSTRACT: The traditionally promulgated perspectives of neuroendocrine neoplasms (NEN) as rare, indolent tumours are blunt and have been outdated for the last 2 decades. Clear increments in their incidence over the past decades render them increasingly clinically relevant, and at initial diagnosis many present with nodal and/or distant metastases (notably hepatic). The molecular pathogenesis of these tumours is increasingly yet incompletely understood. Those arising from the small bowel (SB) or pancreas typically occur sporadically; the latter may occur within the context of hereditary tumour predisposition syndromes. NENs can also be associated with endocrinopathy of hormonal hypersecretion. Tangible advances in the development of novel biomarkers, functional imaging modalities and therapy are espe
SUBMITTER: Clift AK
PROVIDER: S-EPMC9175236 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
ACCESS DATA